Sihuan Pharmaceutical Holdings Group Ltd - Product Pipeline Review - 2016


Posted April 14, 2017 by Shirley

MarketResearchReportStore adds "Sihuan Pharmaceutical Holdings Group Ltd - Product Pipeline Review - 2016" latest studies, published in March 2017. It is a professional and in-depth study on the current state.

 
MarketResearchReportStore adds "Sihuan Pharmaceutical Holdings Group Ltd - Product Pipeline Review - 2016" latest studies, published in March 2017. It is a professional and in-depth study on the current state.

For a sample of this report, please email at: [email protected]

Description
Summary
‘Sihuan Pharmaceutical Holdings Group Ltd - Product Pipeline Review - 2016’, provides an overview of the Sihuan Pharmaceutical Holdings Group Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sihuan Pharmaceutical Holdings Group Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from The proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope
- The report provides a snapshot of the pipeline therapeutic landscape of Sihuan Pharmaceutical Holdings Group Ltd
- The report provides overview of Sihuan Pharmaceutical Holdings Group Ltd including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Sihuan Pharmaceutical Holdings Group Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Sihuan Pharmaceutical Holdings Group Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Request Sample Copy, please email at: [email protected]

Table Of Contents
Sihuan Pharmaceutical Holdings Group Ltd Snapshot 6
Sihuan Pharmaceutical Holdings Group Ltd Overview 6
Key Facts 6
Sihuan Pharmaceutical Holdings Group Ltd - Research and Development Overview 7
Key Therapeutic Areas 7
Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products Glance 13
Sihuan Pharmaceutical Holdings Group Ltd - Late Stage Pipeline Products 13
Pre-Registration Products/Combination Treatment Modalities 13
Sihuan Pharmaceutical Holdings Group Ltd - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Sihuan Pharmaceutical Holdings Group Ltd - Early Stage Pipeline Products 15
IND/CTA Filed Products/Combination Treatment Modalities 15
Preclinical Products/Combination Treatment Modalities 16
Sihuan Pharmaceutical Holdings Group Ltd - Unknown Stage Pipeline Products 17
Unknown Products/Combination Treatment Modalities 17
Sihuan Pharmaceutical Holdings Group Ltd - Drug Profiles 18
BR-01 - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
cinepazide mesylate - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
cyclosporine - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
JK-05 - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
levophencynonate hydrochloride - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27

Browse Complete Report with TOC @
https://www.marketresearchreportstore.com/shop/sihuan-pharmaceutical-holdings-group-ltd-product-pipeline-review-2016

For report sample or more information, please feel free to contact us:
Shirley | Sales Director
Call: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Us
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country United States
Categories Business , Marketing , Reports
Last Updated April 14, 2017